Upon conclusion of this program, participants should be able to:

• Describe the benefits of off-label dosing of FDA approved pharmacotherapy including combination therapy and high-dose NRT
• Translate the concepts of addiction, pharmacotherapy, cognitive-behavioral therapy and relapse prevention into the provision of treatment.

Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.